CALL US: 1.866.734.5291

News & Media

/ News & Media

Drug Makers Made Big Money on America’s Opioid Epidemic, and They Should Pay

The public health crisis created by opioids began with drug companies targeting health care providers with promotional messages.

Media
Dallas Morning News Jeffrey Simon | Contributor This country, Dallas County included, is in the midst of the largest drug epidemic in its history. Approximately 47,000 Americans died in 2017 as a result of opioid-related accidental overdoses, according to the Centers for Disease Control. Every 18 months,…
READ MORE

Simon Greenstone Panatier Secures a $37.2 Million Verdict Against Johnson & Johnson

JnJ to Pay $37.2 Million to Group Blaming Talcum Powder for Cancers

Verdicts
NEW BRUNSWICK, NJ – A New Jersey state court jury awarded $37.3 million to four plaintiffs claiming they developed mesothelioma from inhaling asbestos allegedly present in Johnson & Johnson’s cosmetic talc products. In the first consolidated talc/mesothelioma trial involving multiple plaintiffs, the jury in J&J’s hometown of New Brunswick, New…
READ MORE

Dallas County Trial to Lead the Way in Addressing Opioid Crisis in Texas

Judge announces first four counties in Texas opioid multidistrict litigation

Verdicts
DALLAS – The first Texas trial addressing the role of pharmaceutical manufacturers, distributors and physicians in creating and fueling the state’s opioid crisis has been scheduled for Dallas County next year. Judge Robert Schaffer, who will preside over Texas’ opioid multidistrict litigation (MDL), announced the initial county cases will include…
READ MORE

Simon Greenstone Panatier name two new Shareholders

Newest members of SGP leadership, Darren McDowell & Leah Kagan

Other
Simon Greenstone Panatier is pleased to announce the naming of our newest Shareholders, Darren McDowell and Leah Kagan. Darren & Leah have been outstanding associates with our firm for a number of years. With this addition to the firm leadership, Simon Greenstone Panatier, PC will continue to thrive…
READ MORE
1.866.734.5291 | Email Us
REQUEST A CONSULTATION